Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Current Assets (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Current Assets for 16 consecutive years, with $832.3 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 151.02% to $832.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $832.3 million through Dec 2025, up 151.02% year-over-year, with the annual reading at $832.3 million for FY2025, 151.02% up from the prior year.
  • Current Assets hit $832.3 million in Q4 2025 for Ligand Pharmaceuticals, up from $753.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $832.3 million in Q4 2025 to a low of $220.4 million in Q3 2022.
  • Historically, Current Assets has averaged $370.8 million across 5 years, with a median of $320.2 million in 2023.
  • Biggest five-year swings in Current Assets: tumbled 52.42% in 2021 and later skyrocketed 151.02% in 2025.
  • Year by year, Current Assets stood at $464.8 million in 2021, then tumbled by 43.28% to $263.6 million in 2022, then fell by 9.93% to $237.4 million in 2023, then surged by 39.65% to $331.6 million in 2024, then surged by 151.02% to $832.3 million in 2025.
  • Business Quant data shows Current Assets for LGNDZ at $832.3 million in Q4 2025, $753.9 million in Q3 2025, and $352.9 million in Q2 2025.